Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-13-000247
Filing Date
2013-11-14
Accepted
2013-11-14 12:52:29
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10Q cellcyteform10qsept302013fin.htm 10-Q 275547
2 CERTIFICATION exhibit31.htm EX-31 12407
3 CERTIFICATION exhibit32.htm EX-32 5112
  Complete submission text file 0001056520-13-000247.txt   1573555

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20130930.xml EX-101.INS 176541
5 SCHEMA ccyg-20130930.xsd EX-101.SCH 10764
6 CALCULATION ccyg-20130930_cal.xml EX-101.CAL 15209
7 DEFINITION ccyg-20130930_def.xml EX-101.DEF 8945
8 LABEL ccyg-20130930_lab.xml EX-101.LAB 101004
9 PRESENTATION ccyg-20130930_pre.xml EX-101.PRE 75581
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 131218320
SIC: 2834 Pharmaceutical Preparations